Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
From - National Intelligence Report
Two weeks ago we explained what President Trump's executive order, otherwise known as the travel ban, could mean for labs. We also said that…
From - G2 Compliance Advisor
Section 1557 of the Affordable Care Act bans Medicare participants from committing discrimination on the basis of…
From - National Intelligence Report
Calling the current regulatory system for laboratory developed tests (LDTs) "inadequate and in urgent need of updating," the…
From - Laboratory Industry Report
Laboratory professionals will now have a new tool in the search for knowledge. The American Association for Clinical Chemistry, the NEJM Group, and Area9 Learning are joining forces to…
From - G2 Compliance Advisor
False Claims Act (FCA) and Anti-Kickback (AKS) prosecutions against labs are just two ways the US Justice Department cracks down on…
From - G2 Compliance Advisor
We'll leave it to others to argue whether it's legal, moral or wise. What we can tell you is that President Trump issued an Executive Order Jan. 27, 2017, establishing a…
From - National Intelligence Report
The federal government's return on investment (ROI) in the fight against health care fraud continues a steady decline according to the latest numbers reported for the Health Care Fraud and…
From - Laboratory Industry Report
Fourth quarter earnings reports are starting to trickle in. Here is a big picture roundup of some of the key results so far…
From - National Intelligence Report
The Arizona Attorney General's Office (AGO) recently issued a request for proposal signaling a new legal battle for Theranos…
From - Laboratory Industry Report
In a month with an unusually heavy volume of diagnostic deal making, the headline story was Abbott Laboratories' $25 billion purchase of…